Articles | EuroIntervention

10.4244/EIJV7I3A57 • Jul 29, 2011

Cost analysis of four major drug-eluting stents in diabetic populations

Saadi R, Cohen S, Banko D, Thompson M, Duong M, Ferko N

free

10.4244/EIJV7I3A58 • Jul 29, 2011

Relationship between tissue characterisations with 40 MHz intravascular ultrasound imaging and slow flow during coronary intervention

Utsunomiya M, Hara H, Sugi K, Nakamura M

free

10.4244/EIJV7I3A59 • Jul 29, 2011

Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis

Mercado N, Moe T, Pieper M, House J, Dolla W, Seifert L, Stolker J, Lindsey J, Kennedy KK, Marso S

free

10.4244/EIJV7I3A60 • Jul 29, 2011

Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing

Radu M, Jørgensen E, Kelbæk H, Helqvist S, Skovgaard L, Saunamäki K

free

10.4244/EIJV7I3A61 • Jul 29, 2011

Paclitaxel-iopromide coated balloon followed by “bail-out” bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation

Milewski K, Tellez A, Aboodi M, Conditt G, Yi G, Thim T, Stenoien M, McGregor J, Gray WA, Virmani R, Granada JF, Kaluza G

free

10.4244/EIJV7I3A62 • Jul 29, 2011

Virtual bench testing of new generation coronary stents

Mortier P, De Beule M, Segers P, Verdonck P, Verhegghe B

free

10.4244/EIJV7I3A63 • Jul 29, 2011

Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence

Butera G, Biondi-Zoccai G, Sangiorgi G, Abella R, Giamberti A, Bussadori C, Sheiban I, Saliba Z, Santoro T, Pelissero G, Carminati M, Frigiola A

free

10.4244/EIJV7I3A64 • Jul 29, 2011

Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application

Farooq V, Onuma Y, Radu M, Okamura T, Gomez-Lara J, Brugaletta S, Gogas B, van Geuns R, Regar E, Schultz C, Windecker S, Lefèvre T, Brueren B, Powers J, Perkins L, Rapoza R, Virmani R, Garcia-Garcia H, Serruys PW

free

10.4244/EIJV7I3A65 • Jul 29, 2011

How should I treatsevere calcific coronary artery disease?

Fernandez J, Hobson A, McKenzie D, Talwar S, O'Kane P

free

10.4244/EIJV7I3A66 • Jul 29, 2011

Tools & Techniques: PFO/ASD closure

Pavlovic M, Buellesfeld L, Meier B

free

10.4244/EIJV7I2A29 • Jun 30, 2011

EuroPCR 2011: the ongoing challenge of initiatives and innovations

Serruys PW

free

10.4244/EIJV7I2A30 • Jun 30, 2011

Peripheral interventions: how long will they remain a missed opportunity?

Di Mario C, Roffi M

free

10.4244/EIJV7I2A31 • Jun 30, 2011

Identification of high-risk aortic valve patients

Florath I, Albert A

free

10.4244/EIJV7I2A32 • Jun 30, 2011

Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation

Van Mieghem NM, Nuis R, Tzikas A, Piazza N, Schultz C, Serruys PW, de Jaegere P

free

10.4244/EIJV7I2A33 • Jun 30, 2011

Multicentre experience with the BridgePoint devices to facilitate recanalisation of chronic total coronary occlusions through controlled subintimal re-entry

Werner G, Schofer J, Sievert H, Kugler C, Reifart N

free